EX-21.1 7 tv514406_ex21-1.htm EXHIBIT 21.1

 

Exhibit 21.1

 

SUBSIDIARIES

 

Marker Cell Therapy, Inc.

 

GeneMax Pharmaceuticals, Inc.

 

GeneMax Pharmaceuticals Canada, Inc.